Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00073190 · ClinicalTrials.gov registry record · Phase 1

Patient- and Physician-Based Osteoporosis Education

A Phase 1 study of Osteoporosis and Osteoporosis, Postmenopausal, sponsored by Brigham and Women's Hospital.

Completed
Registry status
Phase 1
Development phase
30,000
Enrollment target
1
Study location

NCT00073190: Completed Phase 1 study of Osteoporosis and Osteoporosis, Postmenopausal, sponsored by Brigham and Women's Hospital.

NCT00073190 is a Phase 1 study of Osteoporosis and Osteoporosis, Postmenopausal that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 30,000 participants, above the 1,189-participant average among 84 other Osteoporosis trials with a reported enrollment target (2423% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00073190, a Phase 1 study of Osteoporosis and Osteoporosis, Postmenopausal, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
Phase 1
Development phase
30,000 participants
Enrollment target
1
Study location

Study Summary

Osteoporosis is an important public health problem. Osteoporosis can cause serious health complications and death and leads to increased medical costs. The purpose of this study is to identify an effective method of educating patients and health care professionals about the diagnosis and treatment of osteoporosis.

Interventions

  • BEHAVIORAL Osteoporosis Education

Study Locations (1)

Massachusetts

  • Daniel H. Solomon MD, MPH - Boston

Trial Details

FieldValue
Enrollment Target 30,000 participants
Start Date 2003-09
Est. Completion 2006-06
Phase Phase 1
Brigham and Women's Hospital

937 total trials

What the finished NCT00073190 record still lists

NCT00073190 is an interventional study that assigns participants to a tested intervention. Its 30,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,189-participant average among 84 other Osteoporosis trials with a reported enrollment target (2423% higher).

The record links to 2 conditions, with Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Osteoporosis Education is the first listed.

NCT00073190 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00073190 about?

NCT00073190 is a clinical study titled "Patient- and Physician-Based Osteoporosis Education". Osteoporosis is an important public health problem. Osteoporosis can cause serious health complications and death and leads to increased medical costs. The purpose of this study is to identify an effective method of educating patients and health care professionals about the diagnosis and treatment o...

What is the current status of trial NCT00073190?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30,000 participants. The study started on 2003-09. Estimated completion is 2006-06.

What conditions does trial NCT00073190 study?

This clinical trial studies the following conditions: Osteoporosis, Osteoporosis, Postmenopausal.

What interventions are being tested in trial NCT00073190?

The interventions under investigation include: Osteoporosis Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT00073190?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00073190 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoporosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00073190's enrollment target sits among peer trials

30,000 2nd of 84 the highest of 84 other Osteoporosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00684580 · 30,000 participants

    Protocol For Collecting Data On Patients With Childhood Cancer

  • NCT03053193 · 30,000 participants

    MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

  • NCT03689595 · 30,000 participants

    Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

  • NCT04834869 · 30,000 participants

    COVID-19 Vaccines Safety Tracking (CoVaST)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00073190, the US trial registry maintained by the National Library of Medicine. NCT00073190 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.